Editorial: infliximab trough levels and histological healing in ulcerative colitis—a step towards personalised biologic therapy

Editorial: infliximab trough levels and histological healing in ulcerative colitis—a step towards personalised biologic therapy

Linked content This article is linked to Papamichael et al. To view this article visit https://doi.org/10.1111/apt.14458.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2018-03, Vol.47 (6), p.855-856
Hauptverfasser: Lobaton, T., De Vos, M.
Format: Artikel
Sprache:eng
Schlagworte:
Biological Therapy
Colitis, Ulcerative
Endoscopy
Gastrointestinal Agents
Humans
Infliximab
Monoclonal antibodies
Tumor necrosis factor-α
Ulcerative colitis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked content This article is linked to Papamichael et al. To view this article visit https://doi.org/10.1111/apt.14458.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14532